Ms Emmanuelle Trombe > McDermott Will & Emery AARPI > Paris, France > Lawyer Profile

McDermott Will & Emery AARPI
23 RUE DE L'UNIVERSITÉ
75007 PARIS
France
Emmanuelle Trombe photo

Work Department

Corporate & Transactional/ Life Sciences

Position

Partner Emmanuelle Trombe represents pharmaceutical, medical device and bio-pharmaceutical companies globally in transactional matters in relation to M&A and divestitures, joint ventures and strategic partnerings, large-scale projects, outsourcing projects, product development, licensing agreements and regulatory matters. She also advises venture capital funds and bio-pharmaceutical companies in connection with a broad range of financing activities.

For further details of Emmanuelle’s biography, please view McDermott website here.

Languages

English
French
Spanish
Italian

Memberships

Médecins sans Frontières, regularly provides contractual advice to this international humanitarian medical association.

Education

École Supérieure de Commerce de Paris (ESCP)
University of Paris II Panthéon-Assas, LLM (Maîtrise), Tax and Commercial Law
Complutense University of Madrid, Master AMSEC

Lawyer Rankings

France > Industry focus: Healthcare and life sciences

(Leading individuals)

Emmanuelle TrombeMcDermott Will & Emery AARPI

The ‘undeniably competent‘ team at McDermott Will & Emery AARPI stands out for its M&A and licencing work, advising key pharmaceutical manufacturers on strategic matters. At the forefront of science, the team handled the acquisition of SK Holdings on behalf of Yposkesi, the first French pharmaceutical manufacturer dedicated to the production of gene and cell therapy drugs for rare diseases. The team is led by Emmanuelle Trombe  and Anthony Paronneau, who are known for their ‘great legal skills as well as for an incomparable knowledge of the life sciences sector.’

Paris > Secteurs et industries > Santé et sciences de la vie

(Les grands avocats du marché)

Emmanuelle TrombeMcDermott Will & Emery AARPI

La «très compétente» équipe de McDermott Will & Emery AARPI est recommandée pour la qualité ses expertises en matière de fusions-acquisitions et de licensing. Le cabinet assiste de grands fabricants pharmaceutiques sur la gestion de leurs questions stratégiques. L’équipe a ainsi participé à l’acquisition de SK Holdings par son client Yposkesi (premier laboratoire pharmaceutique français dédié à la production de médicaments de thérapie génique et cellulaire pour les maladies rares). La pratique est codirigée par Emmanuelle Trombe  et  Anthony Paronneau, qui sont reconnus pour «leurs grandes compétences juridiques et leur connaissance incomparable du secteur des sciences de la vie ».